Authors: HAUBRICH R LALEZARI J FOLLANSBEE SE GILL MJ HIRSCH M RICHMAN D MILDVAN D BURGER HU BEATTIE D DONATACCI L SALGO MP

Citation: R. Haubrich et al., IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE, Antiviral therapy, 3(1), 1998, pp. 33-42

Authors: HAUBRICH R BURGER HU BEATTIE D DONATACCI L SALGO MP

Citation: R. Haubrich et al., SAQUINAVIR PLUS ZALCITABINE VS SAQUINAVIR OR ZALCITABINE MONOTHERAPY IN HIV-INFECTED PATIENTS DISCONTINUING OR INTOLERANT TO ZIDOVUDINE - RESULTS OF A RANDOMIZED, DOUBLE-BLIND TRIAL, AIDS, 10, 1996, pp. 81-81

Authors: SPECTOR SA BLANCHARD S CONNOR EM SALGO MP MCNAMARA J

Citation: Sa. Spector et al., RESULTS OF A CLINICAL-TRIAL COMPARING 2 DOSES OF 2'3'-DIDEOXYCYTIDINE(DDC) IN THE TREATMENT OF CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION WHO WERE INTOLERANT OR HAD FAILED ZIDOVUDINE (ZDV) THERAPY (ACTG-138), Pediatric research, 35(4), 1994, pp. 10000197-10000197

Authors: FISCHL MA OLSON RM FOLLANSBEE SE LALEZARI JP HENRY DH FRAME PT REMICK SC SALGO MP LIN AH NAUSSKAROL C LIEBERMAN J SOO WJ

Citation: Ma. Fischl et al., ZALCITABINE COMPARED WITH ZIDOVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION WHO RECEIVED PREVIOUS ZIDOVUDINE THERAPY, Annals of internal medicine, 118(10), 1993, pp. 762-769